Trial Profile
Alcohol dependence and nalmefene use in Scotland. An ambispective and observational 24 month study utilising informatics to examine the clinical outcome of an alcohol dependent population prescribed Selincro(R)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Adverse reactions; Therapeutic Use
- 12 Mar 2016 Planned End Date changed from 1 Oct 2014 to 1 Mar 2017, according to United Kingdom Clinical Research Network record.
- 13 Nov 2014 New trial record